Segall Bryant & Hamill
AXNX icon

Segall Bryant & Hamill’s Axonics, Inc. Common Stock AXNX Stock Holding History

Segall Bryant & Hamill’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,388
Closed -$2.78M – 608
2024
Q2 		$2.78M Sell
41,388
-15,391
-27% -$1.04M 0.05% 352
2024
Q1 		$3.92M Sell
56,779
-10,301
-15% -$695K 0.07% 266
2023
Q4 		$4.17M Buy
67,080
+9,329
+16% +$522K 0.08% 265
2023
Q3 		$3.24M Buy
+57,751
New +$3.25M 0.04% 372

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Segall Bryant & Hamill's AXNX Position: Q3 2024 in Review

Segall Bryant & Hamill sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 41,388 shares — an estimated $2.78M sold.

Segall Bryant & Hamill first reported a position in AXNX in Q3 2023 and held it in 4 quarters. The position peaked at $4.17M in Q4 2023. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Segall Bryant & Hamill reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Segall Bryant & Hamill sold 41,388 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $2.78M.
  • Segall Bryant & Hamill first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • Segall Bryant & Hamill's Axonics, Inc. Common Stock position peaked at $4.17M in Q4 2023.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.